Childhood Lymphoblastic Leukemia Diet
A person with acute lymphocytic leukemia may benefit from the following diet.
Cancer and Chemotherapy Diet
Adequate nutrition is essential for the body to fight cancer. Unfortunately, cancer and its treatment can cause anorexia, weight loss and malnutrition.
There are two main goals for a cancer diet:
Strategies for evaluating weight loss and anorexia include:
- Determine symptoms that might cause loss of appetite.
- Learn what foods stimulate the appetite.
- Provide nutritional and dietary counseling.
Practical dietary guidelines:
- Atmosphere does make a difference: an attractively set table can help take your mind off a poor appetite.
- Aromas may also help stimulate the appetite, such as freshly baked bread and cookies.
- A glass of wine or beer prior to meals may stimulate the appetite.
- Avoid foods that do not interest you.
- Discuss your eating problems with your doctor.
- Give food a chance: food that sounds unappealing today may sound good tomorrow.
- Stay away from raw eggs and raw meats.
- Take advantage of a good appetite.
- Eat when you feel hungry: do not wait for mealtime.
Benefits of proper nutrition during chemotherapy:
- Improves your tolerance to therapy: a well-nourished body is stronger and more resilient than a poorly nourished one
- Increases the effectiveness of therapy
- Regulates your weight
- Speeds recovery from treatment
Continue to Childhood Lymphoblastic Leukemia Pain in Adults
- Alderton LE, Spector LG, et al. Child and maternal household chemical exposure and the risk of acute leukemia in children with Down's syndrome: a report from the Children's Oncology Group. Am J Epidemiol. 2006 Aug 1;164(3):212-21. 
- Fulcher JW, Allred TJ, et al. Granular acute lymphoblastic leukemia in adults: report of a case and review of the literature. South Med J. 2006 Aug;99(8):894-7. 
- Haferlach T, Kern W, Schnittger S, Schoch C. Modern diagnostics in acute leukemias. Crit Rev Oncol Hematol. 2005 Nov;56(2):223-34. 
- Pui CH, Pei D, Sandlund JT, et al. Risk of adverse events after completion of therapy for childhood acute lymphoblastic leukemia. J Clin Oncol. 2005 Nov 1;23(31):7936-41.